CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,307 | +215.4% | 423 | -4.3% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 442 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 442 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | 0.0% | 442 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | 0.0% | 442 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 442 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | -50.0% | 442 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | +100.0% | 442 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | – | 442 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 442 | -21.6% | 0.00% | – |
| Q4 2019 | $2,000 | – | 564 | +1466.7% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 36 | -99.6% | 0.00% | – |
| Q1 2019 | $136,000 | +30.8% | 10,260 | -21.8% | 0.00% | – |
| Q4 2018 | $104,000 | -11.9% | 13,120 | +23.1% | 0.00% | – |
| Q3 2018 | $118,000 | -22.4% | 10,660 | -6.2% | 0.00% | – |
| Q2 2018 | $152,000 | – | 11,360 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |